Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature
- 1 October 2011
- journal article
- case report
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 41 (2), 265-271
- https://doi.org/10.1016/j.semarthrit.2010.11.003
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- IL‐1: Discoveries, controversies and future directionsEuropean Journal of Immunology, 2010
- Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapyBritish Journal of Haematology, 2009
- Interleukin-1β and the Autoinflammatory DiseasesNew England Journal of Medicine, 2009
- Familial Mediterranean Fever: A review for clinical managementJoint Bone Spine, 2009
- Anakinra: New therapeutic approach in children with Familial Mediterranean Fever resistant to colchicineJoint Bone Spine, 2008
- Treatment of Familial Mediterranean Fever with AnakinraAnnals of Internal Medicine, 2007
- Familial Mediterranean feverRheumatology International, 2005
- Phenotype–genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous featuresRheumatology, 2000
- A candidate gene for familial Mediterranean feverNature Genetics, 1997
- Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean FeverCell, 1997